Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose Intolerance
03 oct. 2017 12h00 HE
|
Ritter Pharmaceuticals
Los Angeles, California,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products...
Stanford Study on Raw Milk Digestibility: Conflicting Interpretations
26 mars 2014 11h37 HE
|
Weston A. Price Foundation
Washington, DC, March 26, 2014 (GLOBE NEWSWIRE) -- Researchers found little difference between the digestibility of
raw versus pasteurized milk, according to a Stanford University
study published in...